Solasia Pharma K.K. (TYO:4597)
Japan
· Delayed Price · Currency is JPY 31.00
-3.00 (-8.82%)
Mar 9, 2026, 3:30 PM JST
Solasia Pharma K.K. Revenue
In the year 2025, Solasia Pharma K.K. had annual revenue of 429.00M JPY with 35.76% growth. Solasia Pharma K.K. had revenue of 338.00M in the quarter ending December 31, 2025, with 43.83% growth.
Revenue
429.00M
Revenue Growth
+35.76%
P/S Ratio
19.46
Revenue / Employee
18.65M
Employees
23
Market Cap
8.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 429.00M | 113.00M | 35.76% |
| Dec 31, 2024 | 316.00M | -301.00M | -48.78% |
| Dec 31, 2023 | 617.00M | -475.00M | -43.50% |
| Dec 31, 2022 | 1.09B | 533.00M | 95.35% |
| Dec 31, 2021 | 559.00M | 105.00M | 23.13% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Morishita Jintan | 12.87B |
| SymBio Pharmaceuticals | 1.31B |
| Wakamoto Pharmaceutical | 9.43B |
| WDB coco | 4.98B |
| Nippon Chemiphar | 32.52B |
| Cyfuse Biomedical K.K. | 230.00M |
| MedRx | 128.00M |
| Taiko Pharmaceutical | 6.40B |